|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
By Industry | By Industry Segment | By Services and Suppliers
| By Location
| By Hotbed |
Profile Search
|
SNBL USA, Ltd.
6605 Merrill Creek Parkway
Everett
Washington
98203
U.S.A.
Phone:
425-407-0121
Fax:
425-407-8601
|
Headquartered in Everett, Washington, SNBL USA, Ltd., the experts in primate research, offers a unique range of safety assessment services to fulfill its commitment to help free patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, SNBL offers programs ranging from regulatory toxicology to customized study designs. SNBL’s specialized capabilities include safety assessment of biologics, reproductive toxicology, cardiovascular, respiratory and CNS pharmacology, immunotoxicology and carcinogenicity. SNBL USA’s state-of-the-art facility can house nearly 4,000 NHPs, and its in-house colony ensures a quick study start. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information, call 425.407.0121 or visit www.snblusa.com.
SNBL USA is a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. With its multiple worldwide facilities and countless skilled and experienced scientists and technicians, SNBL Group works together in providing a full range of drug development services.
SNBL USA Preclinical Service Offerings:
• General Toxicology Studies (DRF, MTD, Acute, Sub-chronic, Chronic)
• PK/TK & PD Studies
• Safety Pharmacology Studies
• Developmental & Reproductive Toxicology Studies
• Carcinogenicity Studies
• Immunotoxicology Studies
• Radiation Studies
• Formulation, Analytical & Bioanalytical Chemistry Services
Other Offerings SNBL USA Provides to Support Your Preclinical Research Requirements
• Rapid Study Initiation
• Quality Reports on Time
• Comprehensive & Ethical Animal Welfare Program
• Industry Expertise in Developmental & Reproductive Toxicology Studies
• Primate Specialists
• Highest Quality Test Systems
• Specialized NHP Programs
• Dedicated Colony for PK Studies
• Expert Flow Cytometry Services
• Strong Regulatory Track Record
• Flexibility & Client-Driven Service
• Anatomic/Clinical Pathology Services
• Full Control of NHP Supply
• Mature NHPs for Toxicology Studies
• Access to a GE Linear Accelerator to facilitate acute radiation syndrome (ARS) studies
SNBL USA Accreditation and Regulatory Support
• Distinguished as a Good Laboratory Practices (GLP) Facility
• Meets regulatory standards of the European OECD Principals of GLP and the Japanese MHLW Standard Ordinance No. 21
• AAALAC Accredited
• PHS Animal Welfare Assurance
• CDC Licensed
• FDA Inspected
SNBL USA SRC Overview
SNBL’s Global Scientific Resource division provides clients with the highest quality NHPs world-wide & provides a single point of contact for their entire NHP supply chain. In the US, SNBL USA Scientific Resource Center (SNBL USA SRC) has been fully operational since July 2007. In addition to NHP sales, SNBL USA SRC provides client boarding and CDC quarantine services. SNBL USA SRC is AAALAC accredited, USDA registered and its modern facility is staffed with a highly qualified experienced team. SNBL USA SRC offerings include:
• NHP Sales
• Contract Quarantine Services
• Client-Specific Colonies
• Client-Specific Buildings
• Indoor/Outdoor Group Housing
• SPF Production Breeding
• Viral & Genetic Screening
• Highest Quality, Adult NHPs
• Large Global Supply of NHPs
• Strong Animal Welfare Program
Email:
Info@snblusa.com
Ownership:
Private
Web Site:
SNBL USA, Ltd.
Employees:
400
Symbol:
|
|
|
Company News |
SNBL USA, Ltd. Announces Consultancy Collaboration With Dr. Pritam Sahota
4/18/2013 10:29:27 AM
More...
|
Steve Glaza Joins SNBL USA, Ltd. as Director of Safety Assessment
1/8/2013 6:40:14 AM
More...
|
SNBL USA, Ltd. Announces Official Letter From the FDA Declaring All Issues Resolved
11/14/2012 11:56:01 AM
More...
|
SNBL USA, Ltd. Receives AAALAC Accreditation for Its Facilities in Wash. and Texas
10/16/2012 11:30:15 AM
More...
|
SNBL USA, Ltd. Protects Its Critical Research Environments With the Metasys® System Implementation
9/25/2012 9:46:08 AM
More...
|
SNBL USA, Ltd. Expands Its Social Housing Program
5/15/2012 10:00:00 AM
More...
|
SNBL USA, Ltd. Demonstrates GLP Compliant Capabilities
5/3/2012 10:28:09 AM
More...
|
SNBL USA, Ltd. Expands Its Business Development with Three New Appointments
4/12/2012 9:55:18 AM
More...
|
SNBL USA, Ltd. to Showcase its Exclusive, Patented Procedure Cage in San Francisco
3/1/2012 7:06:45 AM
More...
|
SNBL USA, Ltd. to Host Developmental Toxicology Session at the 2012 SOT Annual Meeting and ToxExpo in San Francisco, CA
2/24/2012 7:21:08 AM
More...
|
|
|
|
 |
|
|
|
|
|
|